OncoTargets and Therapy
Volume 10, 2017 - Issue
Open access
44
Views
7
CrossRef citations to date
0
Altmetric
Original Research
Therapeutic efficacy and safety of combined BRAF and MEK inhibition in patients with malignant melanoma: a meta-analysis
Peng Chen1 Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, Hubei
, Fuchao Chen2 Department of Pharmacy, Dongfeng Hospital, Hubei University of Medicine, Shiyan, Hubei
& Benhong Zhou1 Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, Hubei;3 School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, People’s Republic of ChinaCorrespondence[email protected]
Pages 5391-5403
|
Published online: 13 Nov 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.